Critique: Is Travel Insurance Worth It? A Guide to Costs, Cancellations, Covera…

Source: bloomberg
Authors: Sara Clemence
URL: https://www.bloomberg.com/news/articles/2026-05-06/is-travel-insurance-worth-it-a-guide-to-costs-cancellations-coverage

What the article reports

Bloomberg's Sara Clemence surveys the US travel insurance market, arguing that standard policies exclude many of the disruptions — war, geopolitical airspace closures, government shutdowns, fuel shortages — currently most likely to affect travelers. The piece walks through major coverage types, CFAR add-ons, credit-card alternatives, and claims best practices. It is framed around recent consumer frustrations and uses one traveler's denied claim as its narrative spine.

Factual accuracy — Adequate

Several specific figures are well-sourced and credible: "Americans spent $5.56 billion on travel insurance in 2024, a 46% increase from 2019" is attributed to the US Travel Insurance Association; Berkshire Hathaway Travel Protection's sales figures (up 15% last year, 7% in Q1 2026) are attributed to the company; MedJet's 48% subscription growth and Global Rescue's 29% sales increase are attributed to each firm respectively.

One verifiable claim is imprecise and potentially disputable: "the US attacked Iran in February." This framing conflates reported strikes on Iranian-backed forces with a direct US attack on Iran — a characterization that, depending on which events are referenced, may overstate the nature of the action and could be contested. The article does not cite a source for this characterization.

The claim that CFAR "reimburses you for some 50% to 75% of already-paid, nonrefundable costs" is a reasonable market-range figure but presented without a source.

The Chase Sapphire Reserve and American Express Platinum benefit figures ($2,500 medical, $100,000 evacuation; $10,000/$20,000 cancellation cap) are specific and checkable — no evident error.

No serious factual errors, but the Iran characterization is the piece's weakest factual moment.

Framing — Tilted

1. Opening anecdote sets the adversarial tone. "I walked in thinking, 'Travel insurance is good, and it will protect me'" — the piece uses a betrayed-consumer voice as its frame before any industry context is offered. The reader is oriented toward skepticism before any pro-insurance perspective appears.

2. Authorial paraphrase presents denied claims as systemic fraud. "It's the implied promise of every travel insurance policy: If something goes wrong, we've got your back… That's simply untrue." This is presented without attribution to the reporter initially — it's a quote from Christopher Elliott, but the paragraph preceding it ("many consumers are finding that… the large print giveth and the small print taketh away") is the author's voice, not a neutral setup.

3. Industry rebuttal is minimal and late. The one direct industry voice — Robert Gallagher of Zurich Cover-More — appears after three paragraphs of negative consumer testimony and is given a single quoted statement. His explanation of why war is excluded ("That would place unsustainable pressure on the shared risk pool") is not followed up with any expert evaluation of whether that rationale is standard practice or contested.

4. Loaded verb choice. "Stonewalling from Priceline" is attributed to the consumer source Popovics but presented without challenge or the company's response — the word "stonewalling" carries a connotation the article lets stand.

5. Positive frame is structurally subordinate. The section "So what is travel insurance actually good for?" appears well into the piece, after extensive coverage of denials — structurally signaling that the affirmative case is secondary.

Source balance

Ratio: 2 clearly critical voices, 1 industry defender, 2 neutral aggregator/media voices, 2 positive consumer voices. On the article's central question — "is insurance worth it?" — critical and skeptical framing dominates the first two-thirds of the piece; positive voices are concentrated at the end. The only insurer quoted is Zurich/Travel Guard, and no independent insurance-law or regulatory expert is included to contextualize exclusion clauses.

Omissions

1. Regulatory context. The article mentions that CFAR is "more difficult to get in states with stricter regulations" but does not explain what those regulations are or why they exist. Readers in New York or Washington get a warning without any explanation.

2. Claims approval rate data. The article references anecdotal denials extensively but does not cite any industry-level data on what percentage of travel insurance claims are actually approved or denied. USTIA or state insurance commissioner data would contextualize whether denials are typical or exceptional.

3. The Iran characterization. "The US attacked Iran in February" is treated as settled fact with no citation, date, or clarifying description of the specific events referenced. A reader unfamiliar with the news cycle cannot verify or contextualize which conflict is meant.

4. Alternative consumer protections. The EU's EC 261/2004 regulation (which gives passengers on EU-departing flights substantial automatic protections for cancellations and delays) is not mentioned — relevant for the many US travelers flying transatlantic routes on European carriers.

5. Insurer claims dispute process. The article advises readers to "call your insurer early" but does not mention state insurance commissioner complaint processes or the role of the National Association of Insurance Commissioners — omitting a key consumer recourse.

What it does well

• Concrete, specific figures throughout: "Americans spent $5.56 billion on travel insurance in 2024, a 46% increase from 2019" gives readers a real sense of market scale rather than vague gestures at growth.
• Clear explanations of product types: the breakdown of "trip cancellation, trip interruption, trip delay, medical expenses, medical evacuation" is cleanly written and genuinely useful to consumers unfamiliar with the distinctions.
• Practical, actionable guidance in the claims section: "save any communications from the airline that state the reason" and "save the receipts for anything you replace, down to the underwear and dental floss" are memorable, specific tips.
• Direct warning against a common upsell: "Don't spring for the 'protect my trip' options offered at airline checkouts — they almost always lead to generic, limited and overpriced coverage" is a clear and consumer-protective call.
• Includes a genuine positive anecdote: the Martha Pearlstone/Italy cancer story demonstrates the article is not categorically anti-insurance.
• Byline is present; sources are identified with affiliations in most cases.

Rating

Overall: 7/10 — A practically useful consumer guide whose skeptical framing and thin industry representation leave readers without the full picture needed to evaluate whether denied claims represent systemic failure or edge-case exclusions.